{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:19:49Z","timestamp":1789478389121,"version":"build-2803163510"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Digestive system cancers are a leading cause of death in China, with a growing projected burden. Yet, data on the lifetime risk (LTR) of these cancers remain limited. We aimed to estimate the LTR of digestive system cancers in China at national and regional levels for 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>For this population-based systematic analysis, we obtained estimates of incidence and mortality of digestive system cancers from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023, alongside population data from the World Population Prospects, China Statistical Yearbook. The LTR of digestive system cancers was estimated with a standard method that adjusts for multiple primaries, taking into account competing risks of death from causes other than cancer and life expectancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The LTR (95% uncertainty interval [UI]) of developing and dying from digestive system cancers in China in 2023 was 11.36% (10.90\u201312.01%) and 8.28% (7.76\u20138.87%), respectively. Males exhibited higher risks for both incidence (10.82%\n                      <jats:italic toggle=\"yes\">vs.<\/jats:italic>\n                      6.85% in females) and mortality (7.58%\n                      <jats:italic toggle=\"yes\">vs.<\/jats:italic>\n                      4.95% in females). The remaining LTR of digestive system cancers decreased with advancing age. Colorectal cancer showed the highest lifetime incidence risk (3.98%), while stomach cancer had the highest lifetime mortality risk (2.69%). Gallbladder cancer consistently demonstrated the lowest risks, with a lifetime incidence of 0.32% and mortality of 0.25%. Geographic disparities were evident, with the highest LTR observed in Eastern and Northeastern regions. Northwestern region had the lowest LTR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In China, approximately one in 9 people will develop and one in 12 will die from digestive system cancers during their lifetime. Significant regional variations highlight the need for precision prevention and tailored health planning.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000004115","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:00:09Z","timestamp":1780542009000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["National and regional lifetime risks of developing and dying from digestive system cancers in China: Findings of the Global Burden of Disease Study 2023"],"prefix":"10.1097","author":[{"given":"Qian","family":"Mao","sequence":"first","affiliation":[{"name":"Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China"},{"name":"National Center for Chronic Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenping","family":"Zhao","sequence":"additional","affiliation":[{"name":"National Center for Chronic Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangmei","family":"Liu","sequence":"additional","affiliation":[{"name":"National Center for Chronic Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Beijing Institute of Geriatrics, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maigeng","family":"Zhou","sequence":"additional","affiliation":[{"name":"National Center for Chronic Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"R1-20260604","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260604","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(25)01635-6","article-title":"The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: A systematic analysis for the Global Burden of Disease Study 2023","volume":"406","year":"2025","journal-title":"Lancet"},{"key":"R3-20260604","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13045-024-01640-8","article-title":"Global burden of cancer and associated risk factors in 204 countries and territories, 1980\u20132021: A systematic analysis for the GBD 2021","volume":"17","author":"Wu","year":"2024","journal-title":"J Hematol Oncol"},{"key":"R4-20260604","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/gutjnl-2024-333227","article-title":"Epidemiology of gastrointestinal cancers: A systematic analysis from the Global Burden of Disease Study 2021","volume":"74","author":"Danpanichkul","year":"2024","journal-title":"Gut"},{"key":"R5-20260604","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/cac2.12197","article-title":"Cancer incidence, mortality, and burden in China: A time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020","volume":"41","author":"Qiu","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"R6-20260604","doi-asserted-by":"crossref","first-page":"259","DOI":"10.46234\/ccdcw2020.067","article-title":"Mortality of common gastrointestinal tract cancers\u2013Huai River Basin, 2008\u20132018","volume":"2","author":"Qi","year":"2020","journal-title":"China CDC Wkly"},{"key":"R7-20260604","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ijc.34301","article-title":"Esophageal cancer in China: Practice and research in the new era","volume":"152","author":"Zhu","year":"2023","journal-title":"Int J Cancer"},{"key":"R8-20260604","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s41256-025-00450-w","article-title":"Critical analysis of the liver cancer policies and programs in China: Implications for international liver cancer control","volume":"10","author":"Chen","year":"2025","journal-title":"Glob Health Res Policy"},{"key":"R13-20260604","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1016\/j.scib.2023.09.041","article-title":"Global, regional, and national lifetime probabilities of developing cancer in 2020","volume":"68","author":"Zheng","year":"2023","journal-title":"Sci Bull (Beijing)"},{"key":"R14-20260604","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S2468-1253(23)00366-7","article-title":"Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: A population-based systematic analysis of GLOBOCAN","volume":"9","author":"Wang","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R15-20260604","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/bjc.2014.606","article-title":"Trends in the lifetime risk of developing cancer in Great Britain: Comparison of risk for those born from 1930 to 1960","volume":"112","author":"Ahmad","year":"2015","journal-title":"Br J Cancer"},{"key":"R16-20260604","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"394","author":"Zhou","year":"2019","journal-title":"Lancet"},{"key":"R17-20260604","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R18-20260604","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R19-20260604","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/bjc.2011.250","article-title":"What is the lifetime risk of developing cancer?: The effect of adjusting for multiple primaries","volume":"105","author":"Sasieni","year":"2011","journal-title":"Br J Cancer"},{"key":"R20-20260604","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1097\/CM9.0000000000003368","article-title":"Global, regional, and national lifetime risk of developing and dying from lung cancer in 2022: A population-based study in 185 countries","volume":"137","author":"Li","year":"2024","journal-title":"Chin Med J"},{"key":"R21-20260604","first-page":"140","article-title":"Lifetime risk of developing and dying from cancer in Henan Province, China: Current status, temporal trends, and disparities","volume":"5","author":"Chen","year":"2025","journal-title":"J Natl Cancer Cent"},{"key":"R22-20260604","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/cac2.12220","article-title":"A global assessment of recent trends in gastrointestinal cancer and lifestyle-associated risk factors","volume":"41","author":"Lu","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"R23-20260604","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s12916-023-03107-y","article-title":"Adherence to the 2018 World Cancer Research Fund (WCRF)\/American Institute for Cancer Research (AICR) Cancer Prevention Recommendations and risk of 14 lifestyle-related cancers in the UK Biobank prospective cohort study","volume":"21","author":"Malcomson","year":"2023","journal-title":"BMC Med"},{"key":"R24-20260604","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1158\/1055-9965.EPI-14-0472","article-title":"Implementation science in cancer prevention and control: A framework for research and programs in low- and middle-income countries","volume":"23","author":"Sivaram","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R25-20260604","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"R26-20260604","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10555-023-10158-3","article-title":"Colorectal cancer: A comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments","volume":"43","author":"Abedizadeh","year":"2024","journal-title":"Cancer Metastasis Rev"},{"key":"R27-20260604","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: A review","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"key":"R28-20260604","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-074962","article-title":"Advances in diagnosis and management of cancer of the esophagus","volume":"385","author":"Deboever","year":"2024","journal-title":"BMJ"},{"key":"R29-20260604","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.3350\/cmh.2024.0824","article-title":"Hepatocellular carcinoma: Updates on epidemiology, surveillance, diagnosis and treatment","volume":"31","author":"Hwang","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"R30-20260604","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2468-1253(22)00044-9","article-title":"Global, regional, and national burden of colorectal cancer and its risk factors, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R31-20260604","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: A systematic analysis for the Global Burden of Disease Study 2019","volume":"8","author":"Kocarnik","year":"2022","journal-title":"JAMA Oncol"},{"key":"R32-20260604","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2468-1253(19)30328-0","article-title":"The global, regional, and national burden of stomach cancer in 195 countries, 1990\u20132017: A systematic analysis for the Global Burden of Disease study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R33-20260604","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","article-title":"Global burden of 5 major types of gastrointestinal cancer","volume":"159","author":"Arnold","year":"2020","journal-title":"Gastroenterology"},{"key":"R34-20260604","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3390\/nu14091764","article-title":"Diet and risk of gastric cancer: An umbrella review","volume":"14","author":"Bouras","year":"2022","journal-title":"Nutrients"},{"key":"R35-20260604","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.3748\/wjg.v29.i16.2452","article-title":"Updates on global epidemiology, risk and prognostic factors of gastric cancer","volume":"29","author":"Yang","year":"2023","journal-title":"World J Gastroenterol"},{"key":"R36-20260604","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102666","article-title":"Evolving landscape of colorectal cancer: Global and regional burden, risk factor dynamics, and future scenarios (the Global Burden of Disease 1990\u20132050)","volume":"104","author":"Zhou","year":"2025","journal-title":"Ageing Res Rev"},{"key":"R37-20260604","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.canlet.2021.09.034","article-title":"Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America","volume":"522","author":"Li","year":"2021","journal-title":"Cancer Lett"},{"key":"R38-20260604","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: A secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin Med J"},{"key":"R39-20260604","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13045-024-01623-9","article-title":"Global cancer statistics for adolescents and young adults: Population based study","volume":"17","author":"Li","year":"2024","journal-title":"J Hematol Oncol"},{"key":"R40-20260604","first-page":"862","article-title":"Cancer incidence in five continents. Cumulative rate and cumulative risk","author":"Day","year":"1992","journal-title":"IARC Sci Publ"},{"key":"R41-20260604","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/oxfordjournals.aje.a009903","article-title":"Standardized lifetime risk","volume":"149","author":"Sasieni","year":"1999","journal-title":"Am J Epidemiol"},{"key":"R42-20260604","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jech.48.6.596","article-title":"Cancer incidence: Life table risk versus cumulative risk","volume":"48","author":"Schouten","year":"1994","journal-title":"J Epidemiol Community Health"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000004115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:00:19Z","timestamp":1780542019000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000004115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":38,"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000004115","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"2025-10-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}